Question 1

Does Vident Advisory own AMLX stock?

Accepted Answer

No. Vident Advisory exited its AMLX (Amylyx Pharmaceuticals) position in Q1 2025. Its Q4 2024 13F listed 10,862 shares worth $41,057.

Question 2

How many shares of AMLX does Vident Advisory own?

Accepted Answer

None since Q1 2025, when Vident Advisory exited the position. Its Q4 2024 13F listed 10,862 shares worth $41,057.

Question 3

What is Vident Advisory's AMLX position worth?

Accepted Answer

Vident Advisory's AMLX position was worth $41,057 in its Q4 2024 13F, before the exit in Q1 2025.

Question 4

Is Vident Advisory buying or selling AMLX?

Accepted Answer

In Q1 2025, Vident Advisory exited its entire AMLX position.

Question 5

When did Vident Advisory first buy AMLX?

Accepted Answer

Vident Advisory first reported AMLX in its Q2 2024 13F and listed it in 3 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$3.66	0
2024-Q4	Decreased	10,862	-30.3%	$41,057	0.0%	$3.84	0
2024-Q3	Increased	15,572	+43.6%	$50,453	0.0%	$3.08	28